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INTRODUCTION
Seminomas are one of the most common tumors of the testis. Bilateral involvement is however uncommon. Coexistence of bilateral seminomas with an adenomatoid tumor has been documented rarely. Epididymal tumors can be picked up on ultrasonography, but the coexisting tumors can pose difficulties and may be missed. Adenomatoid tumors, being benign, can mimic the epididymal spread of testicular tumor clinicoradiologically as well as on histopathology affecting the line of treatment. In the present case, the two tumors could not be separately identified on ultrasonography.
Coexistence of two malignancies is not commonly described in the literature. At times, they can lead to diagnostic dilemma and finally lead to change of treatment regimens accordingly.
CASE REPORT
A 53-year-old man presented with bilateral painless testicular swellings which were slowly increasing in size over the past 6 months. There was no other significant medical or surgical history. On clinical examination, both sides, testes were enlarged. Ultrasound of the scrotum revealed enlarged bilateral testes with large hypo echoic lesion and intact capsules [ Figure 1a ]. Serum beta-human chorionic gonadotropin and alpha-fetoprotein levels were within normal limits. With clinicoradiological diagnosis of seminomas, the patient underwent bilateral high orchiectomy with the removal of left iliac lymph node. Grossly, the left testis was enlarged measuring 9.5 cm × 7 cm × 5 cm and showed a tumor replacing the testicular parenchyma with only a thin rim of normal testicular tissue at the periphery. Right orchiectomy specimen measured 6 cm × 4 cm × 3 cm. There was a tumor in the upper pole, measuring 4.5 cm × 3.5 cm. Normal testicular tissue was identified in the lower pole. Cut surface of both tumors was gray-white, lobulated, and homogenous [ Figure 1b ]. Microscopic examination of both testicular tumors showed classical findings of seminoma composed of cells arranged in nests and lobules surrounded by dense lymphocytic infiltrate. The cells were round to polygonal with a distinct cell membrane, clear to pale eosinophilic cytoplasm, and prominent nucleoli [ Figure 2a ]. In addition, the left testis showed a tumor nodule in the paratesticular region adjacent to the seminomatous component. It was composed of two elements: epithelial-like cells and other fibrous stroma. The cells were large, polyhedral having abundant cytoplasm and were arranged in strands and tubules separated by fibromuscular stroma [ Figure 3a ]. On immunohistochemistry, the tumor cells of seminomas showed diffuse membranous staining with placental alkaline phosphatase (PLAP) [ Figure 2b ] and were negative for calretinin, epithelial membrane antigen (EMA), and HBME-1. The cells in the paratesticular tumor nodule were positive for calretinin [ Figure 3b ], EMA, and HBME-1 suggesting a mesothelial origin. They were negative for PLAP, inhibin, and carcinoembryonic antigen (CEA). Epididymis and spermatic cord of both sides were unremarkable. The left iliac lymph node was free of tumor. The findings were consistent with diagnosis of classic seminoma of bilateral testes (pT1 pN0 pMx) with adenomatoid tumor of the left paratesticular tissue. No adjuvant chemotherapy or radiotherapy was given. Following surgery, the patient was put on hormonal replacement therapy. He had an uneventful recovery and showed no evidence of tumor recurrence or metastasis at 2-year follow-up.
DISCUSSION
Seminoma is the most common pure germ cell tumor of the testis accounting for 35%-50% of all germ cell tumors, with an average age of diagnosis between 15 and 35 years. [1] Bilateral germinative testicular tumors are uncommon, and their synchronous occurrence is even rarer. [2] The diagnosis of classical seminoma is usually straightforward. Variants of seminoma or when it is present as a component of the mixed tumor may pose diagnostic difficulties. Tumor staging has important treatment implications. On the other hand, an adenomatoid tumor is the most common tumor of epididymis, located mostly at its lower pole. They occur usually in the third to fifth decades of life and accounts for 30% of all paratesticular tumors. [3] They have also been reported in spermatic cord, ejaculatory duct, fallopian tube, and uterus. The clinical presentation may vary from asymptomatic to painful nodules. Grossly, they are circumscribed firm, gray-white masses up to 5 cm and may be cystic. Majority of them are readily diagnosed, based on their several typical locations and characteristic microscopic features. [4] The imaging modality of choice for diagnosing scrotal pathologies is ultrasonography. In some lesions originating from tunica of testis, this may pose diagnostic difficulties. [5] In the present case, although tumor morphology of paratesticular nodule was different from seminoma, the proximity to seminoma capsule made it difficult to exclude the possibility of extratesticular spread. On immunohistochemistry, adenomatoid tumors are positive for cytokeratin (CK) and EMA and are negative for CEA. At times, they need to be differentiated from epithelioid hemangioma which is positive for CD34 and negative for keratin. The mesothelial origin of these tumors is proved by its positivity for thrombomodulin, HBME-1, CK 5/6, OC125, and calretinin. [6] Coexistence of these tumors with seminomas has not been described in literature. There is only one case report on Google search that describes the accompaniment of seminoma with adenomatoid tumor. [7] Differentiating adenomatoid tumor in paratestis from extratesticular spread of seminoma can be diagnostically challenging and carries significant diagnostic and therapeutic implications. Although the presence of desmoplastic stroma is one of the characteristic inherent features of adenomatoid tumor, it may be difficult to differentiate it from desmoplastic stroma of infiltrating malignant tumor. Immunohistochemistry is useful as seminomas will be positive for PLAP and negative for CK, EMA, HBME-1, and calretinin.
Awareness of this concurrence is important to establish the correct diagnosis. The knowledge of tumor location and ancillary immunohistochemical studies is helpful in resolving differentials in this situation.
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